“If cannabis use ‘causes’ schizophrenia, it is absolutely impossible that the rate of schizophrenia would not be going up ...

U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

A new study shows risks for premature death associated with CUD. Others show increased memory problems, CUD, depression, ...

“I think the concern is that daily cannabis use has really increased in the last 15 years and at the same time the potency of ...

A new cohort study found that schizophrenia cases related to cannabis use disorder serious enough to warrant a person to seek emergency care increased afte ...

The incidence of cannabis use disorder associated with schizophrenia almost tripled among Canadian teenagers and adults after ...

The proportion of new schizophrenia cases linked to cannabis use in Ontario, Canada, increased from 4% prior to legalization to 10% following. | Cannabis Sciences ...

Cannabis is gaining widespread appeal and a growing number of U.S. states are approving medical marijuana. A large study ...

Cannabis use disorder requiring hospital-based care is linked to an increased risk for premature death in a new cohort study.

The use of medically recommended cannabis by adults is associated with a higher prevalence of cannabis use disorder vs ...

A new effort is underway to legalize not just medical marijuana but recreational use, too. But is that the best route forward ...

The Food and Drug Administration (FDA) has granted Fast Track designation to PP-01 (nabilone/gabapentin) for the mitigation of cannabis withdrawal ...